Karim Adel Hosny

441 total citations
29 papers, 341 citations indexed

About

Karim Adel Hosny is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Karim Adel Hosny has authored 29 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Hepatology and 11 papers in Cancer Research. Recurrent topics in Karim Adel Hosny's work include Liver Disease and Transplantation (10 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Cancer-related molecular mechanisms research (10 papers). Karim Adel Hosny is often cited by papers focused on Liver Disease and Transplantation (10 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Cancer-related molecular mechanisms research (10 papers). Karim Adel Hosny collaborates with scholars based in Egypt, Germany and United States. Karim Adel Hosny's co-authors include Gamal Esmat, Ahmed Ihab Abdelaziz, H.M. El Tayebi, Mohammed Tarif Hamza, Kai Breuhahn, R.A. Assal, Ayman Amin, Shinji Üemoto, Khalid Omar and Refaat Kamel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Karim Adel Hosny

28 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karim Adel Hosny Egypt 10 200 200 77 73 36 29 341
Muhammad Yogi Pratama Indonesia 11 206 1.0× 181 0.9× 40 0.5× 29 0.4× 40 1.1× 24 318
Xinbei Zhou China 6 157 0.8× 152 0.8× 44 0.6× 13 0.2× 69 1.9× 14 276
Baomin Shi China 10 170 0.8× 127 0.6× 61 0.8× 65 0.9× 60 1.7× 16 331
Danfeng Wen China 6 232 1.2× 273 1.4× 88 1.1× 40 0.5× 152 4.2× 6 393
Chengfeng Wang China 5 422 2.1× 423 2.1× 44 0.6× 32 0.4× 78 2.2× 9 539
Ting Xu Tan United States 5 164 0.8× 96 0.5× 86 1.1× 30 0.4× 46 1.3× 6 294
James Lawson Canada 9 236 1.2× 202 1.0× 36 0.5× 35 0.5× 53 1.5× 13 351
Lianying Ge China 12 163 0.8× 112 0.6× 86 1.1× 30 0.4× 101 2.8× 22 354
Guohong Ge China 10 288 1.4× 312 1.6× 146 1.9× 48 0.7× 221 6.1× 18 534
Mina Farag Canada 9 188 0.9× 103 0.5× 67 0.9× 24 0.3× 99 2.8× 23 339

Countries citing papers authored by Karim Adel Hosny

Since Specialization
Citations

This map shows the geographic impact of Karim Adel Hosny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Adel Hosny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Adel Hosny more than expected).

Fields of papers citing papers by Karim Adel Hosny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Adel Hosny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Adel Hosny. The network helps show where Karim Adel Hosny may publish in the future.

Co-authorship network of co-authors of Karim Adel Hosny

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Adel Hosny. A scholar is included among the top collaborators of Karim Adel Hosny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Adel Hosny. Karim Adel Hosny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Assal, R.A., R.A. Youness, Karim Adel Hosny, et al.. (2024). OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma. BMC Gastroenterology. 24(1). 337–337. 2 indexed citations
2.
Hosny, Karim Adel, et al.. (2022). Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC. Life Sciences. 310. 121075–121075. 9 indexed citations
3.
El-Karaksy, Hanaa, Mohamed Said, Naglaa Zayed, et al.. (2021). Resuming post living donor liver transplantation in the COVID-19 pandemic: real-life experience, single-center experience. SHILAP Revista de lepidopterología. 11(1). 92–92. 1 indexed citations
4.
5.
Assal, R.A., Karim Adel Hosny, H.M. El Tayebi, et al.. (2019). Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma. Frontiers in Physiology. 9. 1918–1918. 18 indexed citations
6.
Salman, Ahmed, et al.. (2018). Portal venous pressure and proper graft function in living donor liver transplants in 69 patients from an Egyptian center. Annals of Saudi Medicine. 38(3). 181–188. 3 indexed citations
7.
Assal, R.A., et al.. (2016). miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 4(4). 300–305. 5 indexed citations
8.
Hosny, Karim Adel, et al.. (2016). Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma. World Journal of Hepatology. 8(23). 976–976. 5 indexed citations
9.
10.
Kamel, Refaat, et al.. (2015). Synthetic Graft for Reconstruction of Middle Hepatic Vein Tributaries in Living-Donor Liver Transplant. Experimental and Clinical Transplantation. 13(Supplement 1). 318–322. 9 indexed citations
11.
Hosny, Karim Adel, et al.. (2015). Endothelial cell protein C receptor gene 6936A/G and 4678G/C polymorphisms as risk factors for deep venous thrombosis. Blood Coagulation & Fibrinolysis. 27(3). 259–265. 8 indexed citations
12.
Hamza, Mohammed Tarif, et al.. (2015). miR‐1275: A single microRNA that targets the three IGF2‐mRNA‐binding proteins hindering tumor growth in hepatocellular carcinoma. FEBS Letters. 589(17). 2257–2265. 55 indexed citations
13.
Tayebi, H.M. El, et al.. (2015). Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma. Oncology Letters. 10(5). 3206–3212. 23 indexed citations
14.
Abdelaziz, Omar, et al.. (2015). Intra-operative Ultrasound-guided Thrombectomy and Thrombolysis for Post-operative Portal Vein Thrombosis in Living Liver Donors.. PubMed. 6(1). 33–40. 1 indexed citations
15.
16.
Elbaz, Tamer, et al.. (2013). A retrospective evaluation of causes of exempting living liver donors in an Egyptian centre. Arab Journal of Gastroenterology. 14(1). 10–13. 4 indexed citations
17.
Tayebi, H.M. El, Khalid Omar, Mohamed A. El-Brolosy, et al.. (2013). Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern. Biochemical and Biophysical Research Communications. 434(3). 421–427. 24 indexed citations
18.
Tayebi, H.M. El, Karim Adel Hosny, Gamal Esmat, Kai Breuhahn, & Ahmed Ihab Abdelaziz. (2012). miR‐615‐5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. FEBS Letters. 586(19). 3309–3316. 49 indexed citations
19.
Hosny, Karim Adel, et al.. (2012). Endovascular management of early hepatic artery thrombosis after living donor liver transplantation. Transplant International. 25(8). 847–856. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Yogi Pratama Breakdown of academic impact, for papers by Xinbei Zhou Breakdown of academic impact, for papers by Baomin Shi Breakdown of academic impact, for papers by Danfeng Wen Breakdown of academic impact, for papers by Chengfeng Wang Breakdown of academic impact, for papers by Ting Xu Tan Breakdown of academic impact, for papers by James Lawson Breakdown of academic impact, for papers by Lianying Ge Breakdown of academic impact, for papers by Guohong Ge Breakdown of academic impact, for papers by Mina Farag
Rankless by CCL
2026